Andoy, Richard D.

HRN: 03-51-00  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2024
06/03/2024
IV
500mg
Every 8 Hours
T/C Tonsillar Abscess
Waiting Final Action 
05/27/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/27/2024
06/03/2024
IV
1.5 G
Every 8 Hours
T/C Tonsillar Abscess
Waiting Final Action 
06/07/2024
CO-AMOXICLAV 625MG (TAB)
06/07/2024
06/14/2024
PO
625mg
Q8
Tonsillar Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: